Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ESCALON MEDICAL CORP | esmc_20201231-10qex321.htm |
| EX-31.2 - EX-31.2 - ESCALON MEDICAL CORP | esmc_20201231-10qex312.htm |
| EX-31.1 - EX-31.1 - ESCALON MEDICAL CORP | esmc_20201231-10qex311.htm |
| 10-Q - 10-Q - ESCALON MEDICAL CORP | esmc-20201231.htm |
Exhibit 32.2
Certification pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Mark Wallace, Chief Operating Officer and Principal Accounting & Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Quarterly Report of Escalon Medical Corp. on Form 10-Q for the quarterly period ended December 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 16, 2021
| /s/ Mark Wallace | |||||
| Mark Wallace | |||||
| Chief Operating Officer and Principal Accounting & Financial Officer | |||||